The Terms of Reference for the group were to examine how we managed COVID-19 at the national and global levels, pick up the key learnings both from the success stories and challenges faced, and assess the key gaps which need to be addressed to help us prepare and respond more efficiently and effectively in any such future public health crisis. [...] From examining the lessons learned and challenges faced during the COVID-19 pandemic to recommendations and a roadmap for governance and management of public health emergencies in the future, this report is a starting point for the country’s pandemic preparedness and prevention efforts. [...] From examining the lessons learned and challenges faced from the country’s response and global experience during the COVID-19 pandemic to recommendations and a roadmap for governance and management of public health emergencies in the future, this report is a starting point for the country’s pandemic preparedness efforts. [...] The key challenges are timely detection of early warning signs, the identification of emerging and new pathogens (which could potentially lead to future pandemic threats), the assessment of the public health impact and the implementation of multi-disciplinary surveillance to capture various dimensions of a disease and its impact. [...] » Strengthen real-time surveillance to include the rate of rise and severity of a disease to understand the severity of the pandemic on the ground, incorporating the use of Artificial Intelligence and new tools and technologies.
- Pages
- 80
- Published in
- India
Table of Contents
- TABLE OF CONTENTS 5
- LIST OF ABBREVIATIONS 7
- PREFACE 11
- EXECUTIVE SUMMARY 13
- FUTURE PANDEMIC PREPAREDNESS AND EMERGENCY RESPONSE- A FRAMEWORK FOR ACTION REPORT OF THE EXPERT GROUP 16
- 1. Introduction 16
- Terms of Reference of the Expert Group 18
- 2. Methodology 20
- 3. Lesson from the Past -dealing with epidemics in the last two decades 21
- 4. COVID-19 Learnings and Challenges 24
- 5. Future Pandemic threats Public Health Challenges and Preparedness 27
- 6. Recommendations 29
- 6.1 Governance Legislation Finance and Management 33
- 6.2 Data Management Early Predictive Warning and Surveillance Forecasting and Modelling 38
- 6.3 Research and Innovation Manufacturing Infrastructure Capacity buildingSkilling 45
- Development of Countermeasures 47
- Antiviral Activity 50
- Cytotoxicity 50
- Pharmacokinetics 50
- Efficacy 50
- 6.4 Partnership Community engagement including risk communication Private sector partnerships and international collaborations 56
- 7. Continuous Monitoring of progress to assess action taken 61
- PREPAREDNESS ACTION OUTCOME IMPACT 62
- 8. Indicative Timelines 64
- ANNEXURE - I 65
- ANNEXURE - II 67
- WHO List of Priority Pathogens and diseases 67
- ANNEXURE - III 72
- Future Pandemic Preparedness and Emergency Response Experts Consulted 72
- I. Government Representatives 72
- II. Government Leadership 72
- III. Industry 73
- IV. Technical Institutions 73
- V. Clinicians Microbiologists Virologists and Epidemiologists 73
- ANNEXURE - IV 75
- Key References 75
